Therapeutic Potential of Apatinib Against Colorectal Cancer by Inhibiting VEGFR2-Mediated Angiogenesis and β-Catenin Signaling

PURPOSE: Apatinib is an inhibitor of VEGFR2 (vascular endothelial growth factor receptor 2) that has attracted a great deal of attention due to its promotion of anticancer activity. In the present study, we investigated the therapeutic effects of apatinib against colorectal cancer (CRC) and examined...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Cai, Xiaomin, Wei, Bin, Li, Lele, Chen, Xiaofeng, Yang, Jing, Li, Xiaofei, Jiang, Xiaozheng, Lv, Mu, Li, Mingyang, Lin, Yumeng, Xu, Qiang, Guo, Wenjie, Gu, Yanhong
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7606303/
https://ncbi.nlm.nih.gov/pubmed/33154652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S266549
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados